Nov 13, 2026, 1:43 PMMarkets and investing
AI Capex Slowdown: Jefferies’ Chris Wood Favors Pharma, India, Brazil and China
Jefferies strategist Chris Wood says hyperscalers may cut AI spending, pointing to pharma and India, Brazil and China as alternatives after the midterms.
Listen to this briefingAudio briefing
Summary
Jefferies strategist Chris Wood said midterm elections gave hyperscalers the excuse they needed to reduce spending, according to a MarketWatch report published November 13, 2026. The available feed summary presents the underlying premise conditionally, asking whether the AI capital expenditure narrative is losing momentum.
Wood identified pharma and the markets of India, Brazil and China as ways to position for that slowdown. The source provided limited detail, naming no hyperscalers, companies, spending amounts, percentages, timelines or specific investments.
Positives
- Pharma is the sector Wood identified as a way to position for weakening AI capital expenditure momentum.
- India is one of three markets Wood highlighted as an alternative under the AI spending slowdown thesis.
- Brazil and China were also named as markets that could offer exposure away from the AI capex narrative.
Risks & concerns
- The AI capital expenditure narrative may be losing momentum, according to the conditional premise presented by Wood.
- Hyperscalers had an excuse to cut spending after the midterm elections, according to the report’s characterization of Wood’s view.
- No hyperscalers, spending figures, reduction targets or implementation timelines were disclosed in the available feed summary.
- The limited source text provided no specific pharma companies or investment vehicles tied to Wood’s recommendations.
Primary sourceMarketWatch.com - Top Storieshttps://www.marketwatch.com/story/midterm-elections-provided-the-hyperscalers-with-the-excuse-they-needed-to-cut-back-on-spending-says-jefferies-strategist-de6349ec?mod=mw_rss_topstories
Read full article

